Study Clarifies Chemical Distinction Between Two Types of Modifications in Natural Peptide Products
Scientists have established a chemical and structural benchmark for differentiating two closely related post-translational modifications — 5-thiooxazoles and oxazolone-coupled thioamides — found in ribosomally synthesized, post-translationally modified peptide (RiPP) natural products. The study reassigns the modifications in oxazolin, a bacterial virulence factor, from oxazolones/thioamides to 5-thiooxazoles, correcting a prior characterization. Accurate identification of these modifications matters because they influence the biological function and copper-binding properties of these peptides, with implications for understanding bacterial pathogenesis and natural product discovery.
A new preprint study on bioRxiv reports a framework for distinguishing two structurally similar post-translational modifications (PTMs) that occur in RiPP natural products: 5-thiooxazoles and oxazolone-coupled thioamides. Both modifications are installed by multinuclear nonheme iron-dependent oxidative enzymes (MNIOs) acting on cysteine residues, making them difficult to tell apart using standard analytical approaches. The researchers focused on oxazolin, a copper-binding virulence factor containing six heterocyclic modifications, and compared it in detail with methanobactin, a well-characterized RiPP known to contain oxazolone-coupled thioamides. Through comparative chemical and structural characterization, the team determined that oxazolin's modifications had been previously misassigned and are in fact 5-thiooxazoles rather than oxazolones/thioamides. This reassignment establishes a validated reference point — a benchmark — that researchers can use to correctly classify these PTMs in newly discovered RiPP natural products. The findings have broader relevance for the natural products field, where misidentification of PTMs can lead to incorrect conclusions about biosynthetic pathways, biological activity, and potential therapeutic applications.
What's missing
As a preprint, this work has not yet undergone formal peer review, so the analytical methods and conclusions have not been independently validated by external experts.
What different sources said
- bioRxivCenter
Differentiating 5-thiooxazoles from oxazolone-coupled thioamides in RiPP natural products
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.